singlecare.com 6VCU Health (2026)
Your health is invaluabledon't gamble it on unverified treatments
Monitoring Your Health During Extended Use Year-round use of any medication warrants regular health check-ins
Sparre-Ulrich AH, Gabe MN, Gasbjerg LS et al (2017) GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release
Anecdotal reports from users have included: Commonly Reported: Injection site pain, redness, or swelling Mild dizziness Nausea Fatigue or drowsiness Less Commonly Reported: Anxiety or mood changes Heart palpitations Insomnia Loss of appetite Depression or anhedonia The FDA has noted that BPC-157 may pose an immunogenicity risk (triggering an immune response)
If it's included, review the conditions it's approved for, the tier it falls under (this affects how much you pay), and your expected out-of-pocket costs